Transformational merger brings together Telix’s commercial precision medicine platform with ITM’s scaled radioisotope ...

Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, ...

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease ...

Expanded Unique Dual Index range enables high-throughput laboratories to quadruple multiplexing capacity while retaining ...

Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final ...

US healthtech company Massive Bio has appointed international business development consultancy Intralink to support its ...

Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet ...

Next-generation anti-IgE monoclonal antibody becomes the first biologic candidate in China to file a BLA for seasonal ...

MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced that the first ...

Preliminary MAGMAP trial results in 62 patients show a 96% sentinel node identification rate and no false negatives in the ...

The FACSDiscover A7 Cell Analyzer sets a new standard for experimental standardization in flow cytometry Waters Corporation ...

New stackable chambers provide precise environmental control, remote monitoring and data logging for pharmaceutical, biotech, ...